论文部分内容阅读
目的 :探讨慢性肾衰竭患者进行腹膜透析治疗后的生存率及导致其死亡的危险因素。方法 :对2013年2月至2016年2月期间在喀什地区第一人民医院进行腹膜透析的168例慢性肾衰竭患者的临床资料进行回顾性研究。详细了解这168例患者的基础资料、肾脏原发病、死亡原因及其血红蛋白、血白蛋白、血尿素氮和血肌酐的水平,总结其生存率和导致其死亡的危险因素。结果 :1)在调查结束时,这168例患者中有115例患者继续进行腹膜透析,占68.45%。在其余的53例患者中,有20例患者死亡,有12例患者接受了肾移植手术,有10例患者改行血液透析,有7例患者改行腹膜透析联合血液透析,有4例患者改行其他透析。2)这168例患者1年的生存率为94.04%,2年的生存率为88.09%,3年的生存率为83.33%。3)继续进行腹膜透析的患者与死亡患者在男性患者的例数和血尿素氮的水平方面相比差异无统计学意义(P>0.05)。与死亡患者相比,继续进行腹膜透析患者的年龄更小、患有糖尿病肾病的患者更少,其血红蛋白、血白蛋白及血肌酐的水平均更高,差异有统计学意义(P<0.05)。结论 :进行腹膜透析的慢性肾衰竭患者其3年的生存率较高,导致其死亡的危险因素主要有年龄大、患有糖尿病肾病以及血红蛋白、血白蛋白和血肌酐的水平偏低。
Objective: To investigate the survival rate and risk factors of death after peritoneal dialysis in patients with chronic renal failure. Methods: The clinical data of 168 patients with chronic renal failure who underwent peritoneal dialysis in the First People’s Hospital of Kashi Prefecture from February 2013 to February 2016 were retrospectively reviewed. Learn more about the basic data of 168 patients, primary renal disease, causes of death and hemoglobin, serum albumin, blood urea nitrogen and serum creatinine levels, summarizes the survival rate and risk factors leading to its death. Results: 1) At the end of the survey, 115 of the 168 patients continued peritoneal dialysis, accounting for 68.45%. Of the remaining 53 patients, 20 were fatal, 12 received kidney transplants, 10 received hemodialysis, 7 received peritoneal dialysis and hemodialysis, and 4 switched to other dialysis . 2) The 168 patients had a one-year survival rate of 94.04%, a two-year survival rate of 88.09% and a three-year survival rate of 83.33%. 3) There was no significant difference in the number of male patients and the level of blood urea nitrogen between patients who continued peritoneal dialysis and those who died; (P> 0.05). Patients who continued peritoneal dialysis were younger and had fewer patients with diabetic nephropathy than those who died, with higher levels of hemoglobin, serum albumin, and serum creatinine (P <0.05) . CONCLUSIONS: Patients with chronic renal failure undergoing peritoneal dialysis have a higher 3-year survival rate, and the risk factors for their death are mainly older patients with diabetic nephropathy and lower levels of hemoglobin, serum albumin and serum creatinine.